- Home
- GGT vs OVID Comparison
GGT vs OVID Comparison
Compare GGT & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGT
- OVID
- Stock Information
- Founded
- GGT 1994
- OVID 2014
- Country
- GGT United States
- OVID United States
- Employees
- GGT N/A
- OVID N/A
- Industry
- GGT Trusts Except Educational Religious and Charitable
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- GGT Finance
- OVID Health Care
- Exchange
- GGT Nasdaq
- OVID Nasdaq
- Market Cap
- GGT 144.8M
- OVID 117.3M
- IPO Year
- GGT N/A
- OVID 2017
- Fundamental
- Price
- GGT $4.03
- OVID $1.33
- Analyst Decision
- GGT
- OVID Strong Buy
- Analyst Count
- GGT 0
- OVID 4
- Target Price
- GGT N/A
- OVID $3.13
- AVG Volume (30 Days)
- GGT 59.7K
- OVID 2.0M
- Earning Date
- GGT 01-01-0001
- OVID 11-13-2025
- Dividend Yield
- GGT 15.56%
- OVID N/A
- EPS Growth
- GGT N/A
- OVID N/A
- EPS
- GGT 0.83
- OVID N/A
- Revenue
- GGT N/A
- OVID $6,651,000.00
- Revenue This Year
- GGT N/A
- OVID $1,081.80
- Revenue Next Year
- GGT N/A
- OVID N/A
- P/E Ratio
- GGT $6.90
- OVID N/A
- Revenue Growth
- GGT N/A
- OVID 1070.95
- 52 Week Low
- GGT $4.32
- OVID $0.24
- 52 Week High
- GGT $7.00
- OVID $2.01
- Technical
- Relative Strength Index (RSI)
- GGT 42.73
- OVID 42.22
- Support Level
- GGT $3.93
- OVID $1.34
- Resistance Level
- GGT $4.04
- OVID $1.73
- Average True Range (ATR)
- GGT 0.05
- OVID 0.11
- MACD
- GGT 0.01
- OVID -0.05
- Stochastic Oscillator
- GGT 43.25
- OVID 12.09
About GGT Gabelli Multi-Media Trust Inc. (The)
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.